Oradeo capsule 150mg, manufactured by Orphan Pacific and distributed by Torii Pharmaceutical, contains berotralstat hydrochloride (YJ code: 4490036M1020). This plasma kallikrein inhibitor is indicated for the routine prevention of recurrent attacks of hereditary angioedema (HAE) in adults and adolescents, with a standard dose of 150 mg per capsule.
Oradeo capsule 150mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
